Macrocure

Develops T-cell therapies for wound care

placePetah Tikva, Central District, Israel calendar_todayFounded 2008 groups11 employees language macrocure.com

Innovation

6 patent families (3 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace dormant. Cited 362 times.

YearFilings
20123
20135
20143
20155
20163
20191

Investor mix

3 investors on record; lead investors include Viola Group.

Investor typeCountShare
Venture capital3100%
Coming soon